Test Price
2,800 AEDโ Home Collection Available
ADGRV1 Gene Febrile Seizures, Familial, Type 4 Genetic Test in UAE | 2800 AED | DHA Licensed Lab
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-accredited next-generation sequencing with orthogonal Sanger confirmation.
- Premium Logistics: VIP Mobile Phlebotomy & temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic post-test genetic counseling with a Consultant Medical Genetics for comprehensive result interpretation.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This targeted DNA analysis detects pathogenic mutations in the ADGRV1 gene associated with hereditary febrile seizures type 4 using next-generation sequencing. The test confirms the genetic etiology in families with recurrent febrile seizures, helps predict recurrence risk, and guides clinical management with a turnaround time of 3โ4 weeks at 2800 AED.
| Feature | Our Test (ADGRV1 NGS) | Closest Alternative (Generic Epilepsy Panel) |
|---|---|---|
| Precision | 99.9% analytical sensitivity; full ADGRV1 coverage with Sanger confirmation | 90โ95% coverage; ADGRV1 often excluded |
| Method | NGS (Next-Generation Sequencing) + orthogonal validation | Targeted panel without validation |
| Speed | 3โ4 weeks | 4โ6 weeks |
Physician Insight & Safety Protocols
โThis ADGRV1 genetic test must be interpreted alongside a thorough neurological exam and detailed family pedigree. A negative result does not rule out other genetic or non-genetic causes of febrile seizures. I recommend discussing every finding with your treating neurologist or clinical geneticist.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics โ DHA Registration ID: 9294403
Advisory & Exclusion Guidelines
โ Medication Advisory
Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Safety Red Flags
- Active febrile illness or acute infection requiring immediate medical care.
- Recent (within 24 hours) prolonged seizure or status epilepticus โ stabilize first.
- Known bleeding disorder or inability to provide a venous blood sample safely.
- ER Red Flags: Status epilepticus, seizure lasting >5 minutes, postictal focal deficit, or respiratory distress โ seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What does the ADGRV1 gene test for familial febrile seizures type 4 detect?
ADGRV1 gene testing accurately identifies mutations for familial febrile seizures type 4 via next-generation sequencing. This confirms the genetic etiology in families with recurrent febrile seizures and helps predict recurrence risk. The test requires a simple blood sample and is interpreted within the context of a full genetic counseling session.
2. How should I prepare for the ADGRV1 genetic test?
Before sample collection, a pre-genetic counseling session is mandatory to draw a detailed pedigree chart. No fasting is required; continue prescribed medications unless your doctor advises otherwise.
3. When can I expect the ADGRV1 genetic test results?
Results from the ADGRV1 gene sequencing test are delivered within 3 to 4 weeks. Any detected mutation is confirmed with Sanger sequencing to guarantee 99.9% accuracy. The final report includes targeted clinical recommendations and is reviewed during a post-test telephonic consultation.
UAE Regulatory & Data Privacy Adherence
Data Protection & Clinical Compliance
All genetic test data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient safety and informed consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic information remains confidential and is used solely for diagnostic and clinical management purposes.
Clinical & Logistical Metadata
| Test Name | ADGRV1 Gene Febrile Seizures, Familial, Type 4 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | R56.0 |
| LOINC Code | 94086-1 |
| DHA Facility License & Address | License No. 1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians